dr. bellmunt on challenges with immunotherapy in bladder cancer
Published 6 years ago • 137 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
2:06
dr. bellmunt highlights immunotherapy options in bladder cancer
-
2:58
dr. bellmunt discusses follow-up data for pembrolizumab vs chemotherapy in bladder cancer
-
0:55
dr. bellmunt on immunotherapy combination trials in bladder cancer
-
1:30
dr. bellmunt on pd-l1 data in bladder cancer
-
1:19
dr. bellmunt shares keynote-045 data for pembrolizumab versus chemotherapy in bladder cancer
-
1:34
dr. bellmunt on immunotherapy plus ido in urothelial carcinoma
-
4:43
adjuvant therapy challenges: when to rechallenge immunotherapy and chemotherapy in bladder cancer
-
1:16
dr. bellmunt on the cancer genome atlas project in bladder cancer
-
42:23
bladder cancer | dr. tony talebi discusses "the treatment of stage 1 to 3 bladder cancer?"
-
59:12
കാൻസർ? പേടിക്കാതെ ജീവിക്കാം || cancer live without fear || ep 117
-
22:08
cancer immunotherapy: 2023 research and a look ahead with nina bhardwaj, md, phd
-
1:33
dr. gupta on challenges with perioperative immunotherapy in bladder cancers
-
1:00
dr. black on combinations with durvalumab in bladder cancer
-
1:25
progress and challenges of immunotherapy for bladder cancer
-
0:47
dr. plimack on the challenges with available immunotherapies for bladder cancer
-
0:54
dr. balar on biomarkers of immunotherapy response in bladder cancer
-
1:57
dr. balar on remaining questions with immunotherapy in bladder cancer
-
32:30
bladder cancer and immunotherapy with dr. terence friedlander
-
1:32
dr. balar discusses study of immunotherapy combination in bladder cancer
-
26:56
bladder cancer immunotherapy: building on a history of immune response
-
1:00
dr. apolo on toxicity challenges with checkpoint inhibitors in bladder cancer
-
0:54
dr. o’donnell on challenges with pd-l1 testing in bladder cancer